Report cover image

United States Glucose Monitoring Market Outlook to 2033 - Continuous Glucose Monitors

Publisher GlobalData
Published Dec 31, 2025
Length 65 Pages
SKU # GBDT20775865

Description

United States Glucose Monitoring Market Outlook to 2033 - Continuous Glucose Monitors

Summary

GlobalData’s “United States Glucose Monitoring Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Glucose Monitoring market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments.

The United States Glucose Monitoring Market report provides key information and data on -
  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2025 company share data for Glucose Monitoring Market.
  • Global corporate-level profiles of key companies operating within the United States Glucose Monitoring Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope

United States Glucose Monitoring is segmented as follows -
  • Continuous Glucose Monitors
Reasons to Buy

The United States Glucose Monitoring Market report helps you to develop -
  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

65 Pages
1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 Glucose Monitoring Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Glucose Monitoring Market, United States
3.1 Glucose Monitoring Market, United States, Revenue ($m), 2018-2033
3.1.1 Continuous Glucose Monitors Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Glucose Monitoring Market, United States, Volume (Units), 2018-2033
3.2.1 Continuous Glucose Monitors Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Glucose Monitoring Market, United States, Average Price ($), 2018-2033
3.4 Glucose Monitoring Market, United States, Company Share by Revenue ($m), 2025
4 Overview of Key Companies in United States, Glucose Monitoring Market
4.1 Abbott Laboratories
4.1.1 Company Overview
4.2 DexCom Inc
4.2.1 Company Overview
4.3 Medtronic Plc
4.3.1 Company Overview
5 Glucose Monitoring Market Pipeline Products
6 Recent Developments
6.1 Corporate Communications
6.1.1 Nov 21, 2025: Johnson & Johnson Signs National Charter for Mental Health at Work
6.1.2 Nov 18, 2025: Dedicated Platelet Donor Discovers Health Benefits of A1C Testing
6.1.3 Nov 17, 2025: BD Appoints Robert Huffines And Jacqueline Wright To Board Of Directors
6.1.4 Oct 29, 2025: Glucotrack Appoints Usman Latif, MD, MBA, to Clinical Advisory Team
6.1.5 Oct 17, 2025: USF Health Leads Collaborative Effort to Enhance Type 1 Diabetes Prediction, Prevention, and Treatment
6.1.6 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
6.1.7 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
6.1.8 Apr 23, 2025: Biolinq raises $100m to support US launch of intradermal glucose sensor
6.1.9 Feb 19, 2025: Thermo Fisher Scientific Elects New Director to Board
6.1.10 Jan 21, 2025: Glucotrack Announces ISO 13485:2016 Certification
6.2 Financial Announcements
6.2.1 Nov 05, 2025: Senseonics Holdings, Inc. Reports Third Quarter Financial Results
6.2.2 Oct 22, 2025: Senseonics Holdings Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time
6.2.3 Oct 06, 2025: Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update
6.2.4 Aug 06, 2025: Senseonics Holdings Announces Results for Q2 Ended June 30, 2025
6.2.5 Jul 01, 2025: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 23, 2025
6.2.6 Apr 15, 2025: Johnson & Johnson Announces Q1 2025 Results
6.2.7 Mar 03, 2025: Senseonics Holdings Reports Fourth Quarter and Full Year 2024 Financial Results
6.2.8 Jan 02, 2025: Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 30, 2025
6.3 Government and Public Interest
6.3.1 Jul 24, 2025: Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference
6.3.2 Jun 19, 2025: Mah Sing Healthcare Sdn Bhd Receives 510(K) Clearance For Nitrile Powder Free Examination Glove with Tremella Fuciformis Extract
6.3.3 Apr 16, 2025: Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare Conference
6.3.4 Feb 24, 2025: Thermo Fisher Scientific to Present at TD Cowen 45th Annual Health Care Conference on March 3, 2025
6.3.5 Feb 03, 2025: Johnson & Johnson to Participate in the 45th Annual TD Cowen Healthcare Conference
6.3.6 Jan 07, 2025: New Publication Highlights Safety and Potential Benefits of Redosing Diamyd Precision Medicine for Type 1 Diabetes
6.3.7 Dec 17, 2024: Double Medical Technology Receives 510(K) Clearance For Locking Screw CoCrMo
6.3.8 Dec 12, 2024: Johnson & Johnson to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
6.4 Other Significant Developments
6.4.1 Nov 05, 2025: Senseonics Holdings, Inc. Reports Third Quarter Financial Results
6.4.2 Oct 27, 2025: Lifescan Receives Court Approval of Plan of Reorganization
6.4.3 Oct 22, 2025: Dong-A ST Signs Sales Agreement for CareSens Air with i-SENS
6.4.4 Oct 08, 2025: Linshom Medical Receives 510(K) Clearance For Continuous Predictive Respiratory Monitoring System (CPRMS)
6.4.5 Sep 29, 2025: D. Boral Capital to Host KOL Webinar With World Leading Experts Featuring Insights & Breakthroughs from Enlivex’s Knee Osteoarthritis Program
6.4.6 Sep 16, 2025: Tandem Diabetes Care Publishes Study on Automated Insulin Delivery for Type 2 Diabetes
6.5 Product News
6.5.1 Nov 20, 2025: Stanley Hsia, MD, Presents Phase 2 Trial Results for Mazdutide
6.5.2 Nov 13, 2025: Century Therapeutics Unveils Beta Islet Program for Type 1 Diabetes
6.5.3 Nov 10, 2025: Scientists Identify Trigger for Obesity-Linked Inflammation
6.5.4 Nov 10, 2025: Senseonics Holdings To Participate in the Stifel 2025 Healthcare Conference
6.5.5 Nov 06, 2025: Quebec Expands Access to Dexcom Continuous Glucose Monitoring Systems
6.5.6 Nov 05, 2025: Senseonics Holdings, Inc. Reports Third Quarter Financial Results
6.5.7 Oct 30, 2025: Profusa Outlines Path to $250 Million Revenue by 2030 Driven by Lumee Oxygen and Glucose Monitoring Launches
6.5.8 Oct 14, 2025: OSR Holdings Enters Agreement to Acquire Woori IO for Noninvasive Glucose Monitoring Technology
6.5.9 Oct 13, 2025: MannKind Receives FDA Acceptance for Afrezza Application for Pediatric Diabetes Treatment
6.5.10 Oct 08, 2025: Medical Manufacturing Solutions for Devices and Equipment
6.5.11 Oct 03, 2025: Hong Kong Grants Precision Medicine Patent to Diamyd Medical for Insulin Antigen Treatment in Type 1 Diabetes
6.5.12 Sep 16, 2025: Tandem Diabetes Care Publishes Study on Automated Insulin Delivery for Type 2 Diabetes
6.5.13 Jul 10, 2025: Wristband Sensor Provides All-in-one Monitoring for Diabetes and Cardiovascular Care
6.5.14 Apr 28, 2025: Thermo Fisher Scientific Leverages Integrated Solutions To Accelerate the Development of Biologic Therapeutics
6.5.15 Mar 03, 2025: High School Junior Max Kopp is Pioneering the Future of Wearable Technology, Championed by Crown Wealth
6.5.16 Jan 06, 2025: Introducing isaac by PreEvnt - Non-Invasive Blood Glucose Alert Device at the CES Digital Health Exhibit
6.6 Strategy And Business Planning
6.6.1 Nov 06, 2025: Quebec Expands Access to Dexcom Continuous Glucose Monitoring Systems
6.6.2 Nov 05, 2025: Senseonics Holdings, Inc. Reports Third Quarter Financial Results
6.6.3 Oct 30, 2025: Profusa Outlines Path to $250 Million Revenue by 2030 Driven by Lumee Oxygen and Glucose Monitoring Launches
6.6.4 Oct 22, 2025: Dong-A ST Signs Sales Agreement for CareSens Air with i-SENS
6.6.5 Oct 17, 2025: USF Health Leads Collaborative Effort to Enhance Type 1 Diabetes Prediction, Prevention, and Treatment
6.6.6 Oct 16, 2025: Thermo Fisher Scientific To Accelerate Life Science Breakthroughs With OpenAI
6.6.7 Sep 23, 2025: Glooko Acquires Monarch Medical Technologies to Broaden Diabetes Care Solutions
6.6.8 Sep 17, 2025: Hackensack Meridian Health Launches Your Health On The Move Initiative for Free Health Screenings in New Jersey
6.6.9 May 19, 2025: Actinogen CMO Presents Positive Depression Trial Data at the American Psychiatric Association 2025 Annual Meeting
7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Market Modeling and Forecasting
7.1.5 Company Share Analysis
7.1.6 Benchmarking
7.2 GlobalData Consulting
7.3 Contact Us
7.4 Disclaimer
List of Tables
Table 1: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Continuous Glucose Monitors Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Glucose Monitoring Market, United States, Volume (Units), 2018-2033
Table 4: Continuous Glucose Monitors Market, United States, Volume (Units), 2018-2033
Table 5: Glucose Monitoring Market, United States, Average Price ($), 2018-2033
Table 6: Glucose Monitoring Market, United States, Company Share by Revenue ($m), 2025
Table 7: Glucose Monitoring Market Pipeline Products
List of Figures
Figure 1: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Continuous Glucose Monitors Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Glucose Monitoring Market, United States, Volume (Units), 2018-2033
Figure 4: Continuous Glucose Monitors Market, United States, Volume (Units), 2018-2033
Figure 5: Glucose Monitoring Market, United States, Company Share (%), 2025

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us